IQ Consortium Member Companies


Membership in IQ is open to any corporation and/or any subsidiary thereof which is significantly engaged in the development of new chemical entities or new molecular entities for the prevention, diagnosis or treatment of disease. For information about joining the Consortium, please see Join IQ.

Current IQ Consortium members include:

AbbVie

Agios

Alnylam

Amgen, Inc.

Astellas Pharma US LLC

AstraZeneca Pharmaceuticals

Bayer HealthCare

BeiGene

Bill & Melinda Gates
Medical Research Institute

Biogen

Blueprint Medicines

Boehringer Ingelheim

Bristol Myers Squibb Company

CSL Behring

Daiichi Sankyo

   

Eisai, Inc.

Eli Lilly and Company

EMD Serono Research &
Development Institute, Inc.

Erasca, Inc.

F. Hoffmann-La Roche

Genentech

Gilead Sciences

GSK PLC

Idorsia

Incyte Corporation

Johnson & Johnson

Merck & Co.,Inc.

Mitsubishi Tanabe          

Novartis

Novo Nordisk

 

Organon

Otsuka Pharmaceutical

Pfizer

Relay Therapeutics

Sanofi

Sarepta

Seagen

Servier

Sunovion

Takeda

Teva

UCB Pharma

Vertex, Inc.

Xencor